'Renal dysfunction' presentation slideshows

RESULTS FROM THE 2004 ANNUAL REPORT

RESULTS FROM THE 2004 ANNUAL REPORT. Launched in 1996 UK-wide confidential, voluntary anonymised scheme which aims to collect data on adverse events of transfusion of blood and blood components, and to make recommendations to improve transfusion safety Based at Manchester Blood Centre .

923 views • 80 slides

Chapter 27 Upper GI

Chapter 27 Upper GI. John Noviasky. Upper GI. Includes dyspepsia Peptic ulcer disease Zollingers-Ellison, ZE GERD Stress ulcer prophylaxis. Dyspepsia. Persistent or recurrent pain or discomfort (fullness, bloating, nausea) in upper abdomen 25-55% will experience (fig. 27-1). PUD.

889 views • 72 slides

Dementia: Diagnosis and Treatment

Dementia: Diagnosis and Treatment. Debra L. Bynum, MD Division of Geriatric Medicine University of North Carolina at Chapel Hill. Case .

1.06k views • 70 slides

Antiviral Drugs Prof. Alhaider , 1431 H

Antiviral Drugs Prof. Alhaider , 1431 H. Definition: What are the differences between bacterial and viral infections? Classification of Antiviral Drugs:

1.27k views • 61 slides

EXCRETION OF DRUGS

1.06k views • 59 slides

Ruptured Abdominal Aortic Aneurysms

2.15k views • 42 slides

Not Again!

Not Again!. Secondary Prevention of Future Cardiovascular Events J. Clay Hays, Jr., MD, FACC. 56 yr old insurance man. Presents with chest tightness after playing golf. Trying to walk 18 holes Hypertension on diuretics Not diabetic Unsure of lipids Smoker

402 views • 31 slides

Aprotinin Observational Studies

Aprotinin Observational Studies. Advisory Committee Meeting - September 12, 2007 Rita Ouellet-Hellstrom, Ph.D., M.P.H. FDA CDER Office of Surveillance and Epidemiology Division of Drug Risk Evaluation (DDRE). Objectives.

417 views • 30 slides

The Effects of CPB

641 views • 27 slides

Evaluation of Ascites

Evaluation of Ascites. Andrew Maclennan Morning Report July 24, 2009. Pathophysiology of Ascites. From: Robbins Basic Pathology. Causes of Ascites. Source: UpToDate. Rare Causes of Ascites. Imaging. Ultrasound with Dopplers Easily confirms ascites May see nodularity of cirrhosis

879 views • 24 slides

Biopolymer Processing in Medical Application as Vascular Stents

Biopolymer Processing in Medical Application as Vascular Stents. Reviewed by: AGNES Purwidyantri Student ID No: D0228005. Biodegradable Polymers as Drug Carrier Systems. Polyesters Lactide/Glycolide Copolymers Have been used for the delivery of steriods, anticancer agent, antibiotics, etc.

485 views • 24 slides

Antiretroviral Drug Development: Progress and Challenges

334 views • 23 slides

Abdominal Aortic Aneurysm

1.01k views • 22 slides

The Transition of Chronic-Care Patients from Pediatric to Adult Providers (focusing on Heme/Onc)

The Transition of Chronic-Care Patients from Pediatric to Adult Providers (focusing on Heme/Onc). Meg Browning Med/Peds group seminar series November, 2004. Assumption: This must happen. Are there rules about this? Is it appropriate to have 30-year-olds and 4-year-olds in the same clinic?

484 views • 14 slides

Heart Surgery

Heart Surgery. Georgia Baptist College of Nursing NUR 351 Critical Care Nursing Dr. Kathy Plitnick. Coronary Artery Bypass Surgery. Definition Surgical revascularization procedure Restores blood flow to ischemic heart Goals Relieve symptoms Improve quality of life.

334 views • 10 slides

New Diagnostic Criteria and Management of Acute Kidney Injury Florence Wong, Paolo Angeli

New Diagnostic Criteria and Management of Acute Kidney Injury Florence Wong, Paolo Angeli Journal of Hepatology 2016. New Diagnostic Criteria and Management of Acute Kidney Injury.

477 views • 7 slides

Valsartan in Acute Myocardial Infarction Trial Investigators

VALIANT Trial. Valsartan in Acute Myocardial Infarction Trial Investigators . Presented at American Heart Association Scientific Sessions 2003 Marc A. Pfeffer, et al. N Engl J Med 2003;349:1893-906. VALIANT Trial.

636 views • 5 slides

Valsartan in Acute Myocardial Infarction Trial Investigators

VALIANT Trial. Valsartan in Acute Myocardial Infarction Trial Investigators . Presented at American Heart Association Scientific Sessions 2003 Marc A. Pfeffer, et al. N Engl J Med 2003;349:1893-906. VALIANT Trial.

392 views • 5 slides

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) trial

The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) trial. Randomized, double-blind, multicenter, controlled trial. 4447 patients with type 2 diabetes and at least one additional cardiovascular risk factor, but with no evidence of renal dysfunction

1.62k views • 4 slides

ROCKET AF Renal Dysfunction Substudy

ROCKET AF Renal Dysfunction Substudy. Objective Evaluate the 2950 patients in the per-protocol cohort with a baseline CrCl of 30 to 49 mL/min who received a reduced-dose of rivaroxaban (15 mg/day) compared to those treated with dose-adjusted warfarin Background

407 views • 3 slides